Robyn M Hunter's most recent trade in Tenax Therapeutics Inc was a trade of 30,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tenax Therapeutics Inc | Robyn M Hunter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Tenax Therapeutics Inc | M Robyn Hunter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Tenax Therapeutics Inc | Robyn M Hunter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 100,000 | 100,000 | - | - | Stock Option (right to buy) |